These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 4716652

  • 1. [Clinical studies with a new tocolytic agent (Th 1165 a). Contribution to the management of threatening premature labor].
    Schmidt J, Hirdes G.
    Zentralbl Gynakol; 1973 Mar 16; 95(11):361-9. PubMed ID: 4716652
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of suppression of labor with Th 1165 a and Isoptin on the mother, the new-born and infant (author's transl)].
    Weidinger H, Wiest W, Dietze S, Witzel K.
    Z Geburtshilfe Perinatol; 1973 Oct 16; 177(5):366-72. PubMed ID: 4777494
    [No Abstract] [Full Text] [Related]

  • 3. [The influence of a tocolytic therapy with Th 1165 a on the excretion of total oestrogens in urine in the second half of pregnancy (author's transl)].
    Jütting G, Austermann R, Barényi W, Biemann-Hochstrate C.
    Z Geburtshilfe Perinatol; 1973 Oct 16; 177(5):356-66. PubMed ID: 4777493
    [No Abstract] [Full Text] [Related]

  • 4. [The effect of the calcium inhibitors verapamil (Isoptin) und D 600 on the side effects of the inhibition of labour with the beta-adrenergic drug Th 1165 a (Partusisten)].
    Neubüser D.
    Geburtshilfe Frauenheilkd; 1974 Sep 16; 34(9):782-7. PubMed ID: 4155046
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of early threatened abortion (6th-16th week of pregnancy) using a new tocolytic agent (Th 1165a)].
    Bärmig H, Krzoska C.
    Zentralbl Gynakol; 1974 Jan 11; 96(2):55-8. PubMed ID: 4606038
    [No Abstract] [Full Text] [Related]

  • 6. [Inhibition of labour by hydroxyphenyl-orcipeualin-aerosol (Th 1165 a, fenoterol) (author's transl)].
    Zahn V.
    Geburtshilfe Frauenheilkd; 1973 Oct 11; 33(10):818-21. PubMed ID: 4767408
    [No Abstract] [Full Text] [Related]

  • 7. [Partusisten in obstetrics].
    Zahn V, Johannigmann J.
    Zentralbl Gynakol; 1975 Oct 11; 97(10):605-11. PubMed ID: 1189750
    [Abstract] [Full Text] [Related]

  • 8. [Aspects of the therapy of threatened premature labor].
    Unbehaun V, Conradt A, Meiswinkel E.
    Med Welt; 1972 Dec 16; 23(51):1920-2. PubMed ID: 4145263
    [No Abstract] [Full Text] [Related]

  • 9. [The treatment of late abortion and of threatened premature birth with Th 1165 a combined with Isoptin (author's transl)].
    Weidinger H, Wiest W.
    Z Geburtshilfe Perinatol; 1973 Aug 16; 177(4):233-7. PubMed ID: 4149060
    [No Abstract] [Full Text] [Related]

  • 10. [Action of orciprenaline as an inhibitor of uterine contractions in threatened premature labor. Secondary effects on the maternal cardiovascular system and on the fetal heart rhythm. Clinical contribution].
    Scarpa F, Vucusa C.
    Minerva Ginecol; 1976 Jan 16; 28(1):69-86. PubMed ID: 1256708
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of threatened premature labor. Clinical observations with toxicologic drugs].
    Vangen O.
    Tidsskr Nor Laegeforen; 1973 Apr 30; 93(12):850-2. PubMed ID: 4752586
    [No Abstract] [Full Text] [Related]

  • 12. [Simultaneous application of a beta-adrenergic sympathicomimetic and beta-adrenergic antagonist during inhibition of labor (author's transl)].
    Müller-Tyl E, Reinold E, Hernuss P.
    Z Geburtshilfe Perinatol; 1974 Apr 30; 178(2):128-34. PubMed ID: 4154069
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of isoxsuprine in threatened premature labor and in labor (clinical contribution of 158 cases)].
    Moggian G, Zulli P, Aquilina M, Tamburini E.
    Riv Ital Ginecol; 1976 Apr 30; 57(4-6):363-416. PubMed ID: 1052386
    [No Abstract] [Full Text] [Related]

  • 14. [Practical use of orciprenaline in obstetric emergencies].
    Guzmán Sánchez A, Torres Farías E, Ramírez Esparza C.
    Ginecol Obstet Mex; 1973 Jul 30; 34(201):57-65. PubMed ID: 4727875
    [No Abstract] [Full Text] [Related]

  • 15. Uterine and cardiovascular effects of ritodrine in premature labor.
    Bieniarz J, Motew M, Scommegna A.
    Obstet Gynecol; 1972 Jul 30; 40(1):65-73. PubMed ID: 5044938
    [No Abstract] [Full Text] [Related]

  • 16. [Prospective study on the problem of short-term tocolytic treatment].
    Seifert B, Neef G, Gstöttner H, Röpke F, Woraschk HJ.
    Zentralbl Gynakol; 1974 Oct 18; 96(42):1313-8. PubMed ID: 4458346
    [No Abstract] [Full Text] [Related]

  • 17. [The use of orciprenaline in labor].
    Resta P, Ambrosini A, Polacco V, Tambuscio B.
    Minerva Ginecol; 1976 Jun 18; 28(6):479-85. PubMed ID: 1018829
    [No Abstract] [Full Text] [Related]

  • 18. [Intrauterine pressure and fetal and maternal heart rate on administration of the betamimetic agent, hexoprenaline during labour (author's transl)].
    Bernaschek G, Hondros K, Schaller A.
    Wien Klin Wochenschr; 1981 Sep 18; 93(17):541-7. PubMed ID: 7303700
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of premature labor with a new beta-mimetic agent: pre-par Duphar (Ritodrine). Results in 90 cases].
    Romanini C, Moneta E, Oliva GC.
    Ann Ostet Ginecol Med Perinat; 1972 Dec 18; 93(12):888-904. PubMed ID: 4669292
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical results of treatment with orciprenaline of threatened abortion of premature labor. Use of Alupent in obstetrics].
    Conte D, Cisotto F.
    Minerva Ginecol; 1972 Apr 18; 24(6):309-19. PubMed ID: 4671739
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.